Viewing Study NCT05086627


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2025-12-26 @ 4:16 AM
Study NCT ID: NCT05086627
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2021-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-07-30
Primary Completion Date Type: ACTUAL
Completion Date: 2024-08-20
Completion Date Type: ACTUAL
First Submit Date: 2021-09-15
First Submit QC Date: None
Study First Post Date: 2021-10-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-21
Last Update Post Date: 2024-08-22
Last Update Post Date Type: ACTUAL